Brain-Machine Interfaces, Implantables, And Neuroprosthetics: 10 NeuroTech Startups Targeting Your Brain
These startups have seen investment from NEA, Andreessen Horowitz, and DARPA, among many others.
These startups have seen investment from NEA, Andreessen Horowitz, and DARPA, among many others.
We used the CB Insights database to identify companies that are using AI to expedite various stages of the clinical trial process, from drug formulation to patient recruitment.
We used clinical trial data to map some of the most promising drug startups to their stage of development in this pharma market landscape.
Notable exits of 2017 so far include the acquisition of Delinia by Celgene and the IPO of Jounce Therapeutics.
California pharma deals expected to decrease for the second consecutive year.
Phase 2 and Pre-clinical/Phase 1 companies with lead drug candidates targeting oncology lead aggregate funding in the space.
Startups are applying innovative techniques to cure the common cold, re-engineer the human microbiome, and fight against cancer.
Google more than doubled pharma investments in each of the last two years.
OrbiMed, Novartis, and NEA lead as the most active investors in pharma startups since 2013.
The majority of deals to pharma companies are seed, angel, and Series A rounds.
The tech giant now appears to be attacking this industry from two directions, including direct investments and internal development of pharma-targeted efforts.